0
Pulmonx Corporation Banner Image

Pulmonx Corporation

  • Ticker LUNG
    Exchange NASDAQ More
  • Industry Medical Appliances & Equipment More
  • Sector Healthcare More
Pulmonx Corporation Logo Image
  • 201-500 Employees
  • Based in Redwood City, California
Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for severe lung disease. Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System and StratX® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. Pulmonx received FDA pre-marketMore approval to commercialize the Zephyr Valve following its designation as a “breakthrough device.” The Zephyr Valve is commercially available in more than 25 countries, with over 100,000 valves used to treat more than 25,000 patients.
REPORT RATINGS
5.0 / 5.0 (1)

Pulmonx Corporation reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Pulmonx Corporation

Most Recent Responsibility Report

Pulmonx Corporation
MOST RECENT 2023 Environmental, Social and Governance Summary Report

Pulmonx Corporation does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information
Our service enables potential investors to review the most recent and archived Pulmonx Corporation Sustainability Report, Pulmonx Corporation Corporate Social Responsibility Report, Pulmonx Corporation CSR Report, Pulmonx Corporation Corporate Responsibility, Pulmonx Corporation CR Report, Pulmonx Corporation Citizenship Report, Pulmonx Corporation ESG Report, and Pulmonx Corporation Environmental Report online.
Pulmonx Corporation Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!